U.S. Government Urgently Seeking Data on Puzzling COVID-19 Relapses After Taking Pfizer’s New Pill
U.S. government researchers are urgently planning studies of how often and why SARS-CoV-2 levels rebound in some COVID-19 patients who have completed a five-day course